-
Methylome of medulloblastoma data (MB_COMICS cohort)
Study
EGAS00001007815
-
The evolution of ovarian high grade serous carcinoma from STIC lesions
Study
EGAS50000000360
-
The evolution of ovarian high grade serous carcinoma from STIC lesions
Study
EGAS50000000361
-
Primary central nervous system lymphoma (PCNSL) biopsies show heterogeneity in gene expression profiles, genetic subtypes, and in vitro drug sensitivity to kinase inhibitors
Study
EGAS50000000312
-
DCLRE1B/Apollo germline mutations associated with renal cell carcinoma
Study
EGAS50000000216
-
Single-cell RNA sequencing of human skin tumors (BCC, SCC and Melanoma)
Study
EGAS50000000365
-
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.
Study
EGAS50000000371
-
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Study
EGAS50000000381
-
AYA glioma NGS
Study
EGAS50000000383
-
Genomic characterization of retinoblastoma
Study
EGAS00001005248
-
Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.
Study
EGAS00001005667
-
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma.
Study
EGAS50000000395
-
RNA-Seq data_MM study cohort (n=73) and human myeloma cell lines
Study
EGAS50000000392
-
Array-based methylation analysis of SDHB-deficient pheochromocytoma and paraganglioma
Study
EGAS00001007844
-
WGS of primary neuroblastoma data
Study
EGAS50000000348
-
WGS of ecDNA neuroblastoma cell lines
Study
EGAS50000000349
-
RNAseq of medulloblastoma data (MB_COMICS cohort)
Study
EGAS50000000410
-
Cell-Free DNA Genomic and Fragmentomic Features for Early Outcome Prediction in Diffuse Large B-Cell Lymphoma
Study
EGAS50000000412
-
Single-cell RNA sequencing of pediatric Hodgkin Lymphoma to study the inhibition of T cell subtypes
Study
EGAS50000000432
-
Transcriptomics sequencing analysis of pre-invasive lung adenocarcinoma in never-smokers
Study
EGAS50000000439
-
MBD4 targeted sequencing
Study
EGAS00001005012
-
Multiple Myeloma GWAS Meta-analysis
Study
EGAS50000000292
-
Combined single-cell transcriptomics and T-cell receptor sequencing reveal heterogeneity of mycosis fungoides between and within patients and identify a CD4+ cytotoxic subtype
Study
EGAS50000000226
-
Spatially resolved transcriptomics reveals profound subclonal heterogeneity and T cell dysfunction in extramedullary myeloma
Study
EGAS50000000227
-
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
Study
EGAS00001004525
-
Drug Development against Tumor Microtube Networks in Glioblastoma
Study
EGAS50000000477
-
The variable genomic landscape during osteosarcoma progression: insights from a longitudinal WGS analysis
Study
EGAS50000000329
-
Personalized peptide vaccination among 173 patients with IDH wildtype glioblastoma: a retrospective analysis
Study
EGAS50000000449
-
Identifying New Genetic Subtypes in Follicular Lymphoma
Study
EGAS50000000435
-
Disease recurrence after pathologic response (Recurrence DNAseq)
Study
EGAS50000000488
-
Immune signature of malignant melanoma in pregnancy
Study
EGAS50000000492
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma
Study
EGAS00001004558
-
BulkRNAseq - Notch Signaling Maintains a Progenitor-Like Subclass of Hepatocellular Carcinoma
Study
EGAS50000000515
-
Large B cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
Study
EGAS50000000564
-
ATACseq - Notch Signaling Maintains a Progenitor-Like Subclass of Hepatocellular Carcinoma
Study
EGAS50000000516
-
scRNAseq - Notch Signaling Maintains a Progenitor-Like Subclass of Hepatocellular Carcinoma
Study
EGAS50000000517
-
Target sequencing for 53 synovial sarcoma patients
Study
EGAS50000000522
-
Single-cell transcriptomics of neuroblastoma tumors
Study
EGAS50000000223
-
Contribution of specific cell types to the development of Barrett’s esophagus and carcinoma via germline genetic risk
Study
EGAS50000000530
-
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms
Study
EGAS50000000485
-
Single cell RNA and ATAC sequencing data from GBM patients
Study
EGAS50000000547
-
Genomic Profile of Multiple Localised Spiradenoma and Spiradenocarcinoma
Study
EGAS50000000554
-
Divergent WNT Signaling and Drug Sensitivity Profiles within Hepatoblastoma Tumors and Organoids
Study
EGAS50000000561
-
Identification and characterization of tertiary lymphoid structures in brain metastases
Study
EGAS50000000563
-
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Study
EGAS50000000525
-
3D genome topology distinguishes molecular subgroups of medulloblastoma
Study
EGAS50000000540
-
Multiple myeloma treated with T-cell redirecting immunotherapies
Study
EGAS50000000546
-
Whole exome sequencing of pre-invasive lung adenocarcinoma in non-smokers
Study
EGAS50000000438
-
Selective Elimination of Immunosuppressive T cells in Patients with Multiple Myeloma
Study
EGAS00001004915
-
Characterization of copy number quiet oral cancer
Study
EGAS50000000558
-
Tumor Evolution Analysis Uncovered Immune-Escape Related Mutations in Relapsed Diffuse Large B-Cell Lymphoma
Study
EGAS50000000032
-
Cancer cell and tumor microenvironment biomarkers associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial
Study
EGAS50000000560
-
Transcriptome analysis of leiomyosarcoma
Study
EGAS50000000594
-
Targeted gene panel sequencing of leiomyosarcoma
Study
EGAS50000000595
-
Tumor Profiler Melanoma Study
Study
EGAS50000000599
-
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
Study
EGAS50000000600
-
Reconstructing oral cavity tumor evolution through brush biopsy
Study
EGAS50000000602
-
Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue
Study
EGAS50000000584
-
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
Study
EGAS50000000631
-
Ultra-sensitive ctDNA monitoring required for predicting response and resistance to immunotherapy in advanced melanoma
Study
EGAS50000000550
-
Single cell multi-omics analysis of chromothriptic medulloblastoma highlights genomic and transcriptomic consequences of genome instability
Study
EGAS00001005410
-
RNA sequencing data from glioblastoma primary cell lines treated with indisulam
Study
EGAS50000000680
-
Fragmentomic features of individuals with different cfDNA concentrations
Study
EGAS50000000692
-
RNA sequencing of follicular T cell lymphoma
Study
EGAS00001004646
-
WGS of CTCs enriched using high-throughout microfluidic device from entire cancer patient leukopak
Study
EGAS50000000723
-
RNAseq samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000728
-
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes
Study
EGAS50000000714
-
Distinct immune cell infiltration patterns in PDAC exhibit divergent immune cell selection and immunosuppressive mechanisms
Study
EGAS50000000726
-
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Study
EGAS50000000710
-
Epstein-Barr Virus status drives morphological and molecular intra-tumour heterogeneity in gastric cancer: insights from a case report and literature review
Study
EGAS50000000706
-
Bladder cancer subtyping study across 4 atezo clinical trials
Study
EGAS50000000497
-
MET amplification in gastric cancer
Study
EGAS50000000744
-
The genetic footprint of the European Roma diaspora: Evidence from the Balkans to the Iberian Peninsula
Study
EGAS50000000746
-
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: CheckMate 649 biomarker analyses
Study
EGAS50000000747
-
Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research
Study
EGAS50000000757
-
Djerroudi et al., E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000000761
-
Analysis of T cells in follicular lymphoma
Study
EGAS50000000778
-
Genomic Profiling of an anti-PD-L1 treated cohort of Newly Diagnosed GBM patients
Study
EGAS50000000783
-
Transcriptomic Profiling of an Anti-PD-L1 Treated Cohort of Newly Diagnosed GBM Patients
Study
EGAS50000000784
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000801
-
Genomic analysis of head and neck squamous cell carcinoma upon acquired resistance to cetuximab
Study
EGAS50000000800
-
Blood-based monitoring of relapsed/refractory cHL patients predict responses to PD-1 blockade treatment
Study
EGAS00001005894
-
Diagnostic Genomic Analysis is Prognostic in AYA ALL Patients Treated on a MRD-Stratified Paediatric Protocol
Study
EGAS50000000752
-
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
Study
EGAS50000000770
-
A Phase Ib/II Study of Regorafenib and Paclitaxel in Beyond First-line Advanced Esophagogastric Carcinoma (REPEAT)
Study
EGAS00001006054
-
Tumor-reactive heterotypic CD8 T cell clusters from clinical samples
Study
EGAS50000000785
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000803
-
Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor
Study
EGAS50000000811
-
Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
Study
EGAS50000000809
-
Whole Exome Sequencing of a Lung Adenocarcinoma Patient Across Three Time Points
Study
EGAS50000000812
-
Single Cell RNA Transcriptomics of Mantle Cell Lymphoma Reveals the Presence of Treatment-Resistant Subclones at the Time of Diagnosis
Study
EGAS50000000825
-
Tumor-resident T-cell regulate responses to checkpoint blockade immunotherapies
Study
EGAS50000000826
-
Molecular biomarkers for stratification periheral T cell lymphoma
Study
EGAS00001006691
-
Whole Genome Sequencing of Neuroblastoma
Study
EGAS00001000222
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Inferring tumor genomes from peripheral blood i.e. CTCs and plasma-DNA using deep sequencing and targeted enrichment
Study
EGAS00001000337
-
Whole-genome-Sequencing of adult medulloblastoma
Study
EGAS00001000393
-
AUBTRG - Whole Exome Sequencing of Diffuse Glioma Samples
Study
EGAS00001003035
-
Integrated Genomic and Transcriptomic Analysis Reveals Unique Characteristics of Hepatic Metastases and Pro-metastatic Role of Complement C1q in Pancreatic Ductal Adenocarcinoma
Study
EGAS00001004821
-
Single-cell analysis of retinoblastoma heterogeneity
Study
EGAS00001005178